HLA haplotypes, polysomnography, and pedigrees in a case series of patients with narcolepsy

Sleep

Volumn 20, Issue 10, 1997, Pages 850-857

  Hayduk, Roza ^a   Flodman, Pamela ^b   Spence, M Anne ^b   Erman, Milton K ^a   Mitler, Merrill M ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cataplexy; Genetics; HLA; Narcolepsy; Polysomnography

Indexed keywords

HLA ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN; IMIPRAMINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CATAPLEXY; CLINICAL ARTICLE; FEMALE; HAPLOTYPE; HLA TYPING; HUMAN; MALE; MONOZYGOTIC TWINS; NARCOLEPSY; PEDIGREE ANALYSIS; POLYSOMNOGRAPHY; PRIORITY JOURNAL; SLEEP DISORDER; SYMPTOMATOLOGY;

EID: 0030862232     PISSN: 01618105     EISSN: None     Source Type: Journal    
DOI: 10.1093/sleep/20.10.850     Document Type: Article

References (21)

1. Hublin C, Partinen M, Kaprio J, et al. Epidemiology of narcolepsy. Sleep 1994;17:S7-S12.
2. Juji T, Satake M, Honda Y, et al. HLA antigens in Japanese patients with narcolepsy. All the patients were DR2 positive. Tissue Antigens 1984;24:316-9.
3. Langdon N, Welsh KI, van Dam M, et al. Genetic markers in narcolepsy. Lancet 1984;2:1178-80.
4. Billiard M, Seignalet J. Extraordinary association between HLA-DR2 and narcolepsy. Lancet 1985;1:226-7.
5. Mueller-Eckhardt G, Meier-Ewert K, Schendel DJ, et al. HLA and narcolepsy in a German population. Tissue Antigens 1986; 28:163-9.
6. Poirier G, Montplaisir J, Lebrun A, et al. HLA antigens in narcolepsy and idiopathic hypersomnia. Sleep 1986;9:153-8.
7. Rubin RL, Hajdukovich RM, Mitler MM. HLA-DR2 association with excessive somnolence in narcolepsy does not generalize to sleep apnea and is not accompanied by systemic autoimmune abnormalities. Clin Immunol Immunopathol 1988;49:149-58.
8. Marsh SG. Nomenclature for factors of the HLA system, update June 1996. Tissue Antigens 1996;48:233-4.
9. Marsh SG. Nomenclature for factors of the HLA system, update May 1996. Tissue Antigens 1996;48:141-2.
10. Mignot E, Kimura A, Lattermann A, et al. Extensive HLA class II studies in 58 non DRB1*15 (DR2) narcoleptic patients with cataplexy. Tissue Antigens 1997;49:329-41.
11. Guilleminault C, Grumet C. HLA-DR2 and narcolepsy: not all narcoleptic-cataplectic patients are DR2. Hum Immunol 1986; 17:1-2.
12. Sleep Disorders Classification Committee, Roffwarg HP, Chairman. Diagnostic classification of sleep and arousal disorders. Sleep 1979;2:1-137.
13. Aldrich MS. The clinical spectrum of narcolepsy and idiopathic hypersomnia. Neurology 1996;46:393-401.
14. Guilleminault C, ed. Sleeping and waking disorders: indications and techniques. Menlo Park, CA: Addison-Wesley, 1982.
15. Diagnostic Classification Steering Committee, Thorpy MJ, Chairman. International classification of sleep disorders: diagnostic and coding manual. Rochester. MN: American Sleep Disorders Association, 1990.
16. Mitler MM, Shafor R, Hajdukovich R, et al. Treatment of narcolepsy: objective studies on methylphenidate, pemoline, and protriptyline. Sleep 1986;9:260-4.
17. Neale MC, Cardon LR. Methodology for genetic studies of twins and families. Boston: Academic Publishers, 1992.
18. Akane A, Matsubara K, Shiono H, et al. Diagnosis of twin zygosity by hypervariable RFLP markers. Am J Med Genet 1991;41:96-8.
19. Hayduk R, Flodman P, Spence MA, et al. Monozygotic twins with narcolepsy: preliminary report. Sleep Res 1996; 25:252.
20. Hayduk R, Flodman P, Spence MA, et al. Narcolepsy genetic study: HLA findings. J Sleep Res 1996;5:89.
21. Mignot E, Hayduk R, Black J, et al. HLA class II studies in 509 narcoleptic patients. Sleep Res 1997;26:433.